The difference between AB and FS metrics (AB-FS) for amides and amines (positive differences in both cases, indicating AB > FS values) allowed identifying two subgroups in IDH-mutant_1p/19qret gliomas: those with and those without AB/FS mismatch. This evidence concerns the gene IDH1 and central nervous system cancer.